Changes in the U.S. Pharmaceutical Import Mix under the Agreement on Trade in Pharmaceutical Products

The zero-for-zero initiative on pharmaceuticals contributed to both the substantial increase in U.S. pharmaceutical imports during the past 20 years and the growing share of such imports held by formulated (dosage-form) products. Under the initiative, the United States and its major trading partners reciprocally removed tariffs on many pharmaceuticals, their derivatives, and certain chemical intermediates used to make pharmaceuticals

MoreLess

Year of publication:	2018
Authors:	Nesbitt, Elizabeth
Publisher:	[2018]: [S.l.] : SSRN
Subject:	USA \| United States \| Pharmaindustrie \| Pharmaceutical industry \| Arzneimittel \| Pharmaceuticals \| Arzneimittelmarkt \| Pharmaceutical market

freely available

Full text |

More access options

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (2 p)
Type of publication:	Book / Working Paper
Language:	English
Notes:	In: U.S. International Trade Commission (USITC), Executive Briefings on Trade, August 2017 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments August 2017 erstellt
Classification:	F23 - Multinational Firms; International Business ; F13 - Commercial Policy; Protection; Promotion; Trade Negotiations ; O3 - Technological Change; Research and Development ; L65 - Chemicals; Rubber; Drugs; Biotechnology
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10012915855